Fay Nugent
Recent publications
-
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.
Silk SE. et al, (2024), Lancet Infect Dis, 24, 1105 - 1117
-
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Silk SE. et al, (2023), Med, 4, 668 - 686.e7
-
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Hou MM. et al, (2023), Sci Transl Med, 15
-
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Salkeld J. et al, (2022), Front Immunol, 13